Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albuterol Dose-Response in Preterm Infants at Risk of BPD
NCT02447250Phase 4Completed
- Sponsor
- Oregon Health & Science University
- Start
- Oct 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of salbutamol in bronchopulmonary dysplasia (BPD), sponsored by Oregon Health & Science University. Started Oct 2013; status: completed.
02
Drugs
salbutamol
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT02447250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02447250.